Home / Healthcare/ Sri Lanka’s first portable clinical-quality ECG Avidhrt Sense now at Dialog

Sri Lanka’s first portable clinical-quality ECG Avidhrt Sense now at Dialog

Comments / {{hitsCtrl.values.hits}} Views / Monday, 14 January 2019 00:00


From left: Dialog Axiata Product and Service Innovation Head Chathura Peiris, Avidhrt Inc. Chairman Prabode Weebadde, National Hospital of Colombo Consultant Cardiologist Dr. Sampath Withanawasam, Dialog Axiata Group Chief Operating Officer Dr. Rainer Deutschmann, University of Kelaniya Faculty of Medicine Senior Lecturer Dr. Wasanthi Subasinghe, PhD (USA) and My Health Solutions Limited Director/CEO Sameera Wijerathna

Dialog Axiata PLC, Sri Lanka’s premier connectivity provider, MyDoctor.lk and Avidhrt Inc. have partnered to launch Avidhrt Sense, the country’s first and only portable vital monitor, available to the Sri Lankan public. 

Avidhrt Sense is the only commercial product that offers a complete physiological monitoring solution for patients and health-conscious individuals.

Patients with suspected heart conditions, arrhythmia (primarily atrial fibrillation), or other heart-related illnesses, can use Avidhrt Sense to monitor cardiac rhythm, measure blood oxygen (SpO2) levels including hypoxia and measure body and ambient temperature. Health-conscious individuals can use Avidhrt Sense to monitor heart rate recovery and exercise capacity.

The device is primarily key for patients who have recently experienced heart surgery, cardiac stent placement, arrhythmia surgery or those that have recently suffered an embolic stroke, in order to continuously monitor and record their ECG. Additionally, understanding SpO2 levels, body and environmental temperature, can give further insight into other health conditions.

Further, the Avidhrt solution is inclusive of a mobile-based application (available on the Apple App Store and Google Play Store) to manage and store baseline data, readings and general reports that can be sent directly to an on-demand healthcare network via service partner MyDoctor, Sri Lanka’s pioneering digital health solution provider, for consultations or second opinions.

Avidhrt CEO Dr. Robert Frank said: “Avidhrt is pleased to partner with Dialog Axiata. Avidhrt is an innovative cardiac health company with offices in the US, Sri Lanka and India. The first commercial product of Avidhrt is an affordable, handheld cardiac monitor, powered by cloud-based machine learning technology. Avidhrt is the recipient of a prestigious National Science Foundation (U.S.) award to work on mobile solutions to prevent the cardiac events in firefighters. The innovative solutions created by Avidhrt are in synch with Dialog’s focus to use emerging technologies such as IoT (Internet of Things), Big Data, Cloud Computing and Artificial Intelligence to transform lives.”

Dialog Axiata Group Chief Operating Officer Dr. Rainer Deutschmann said: “Dialog has been at the forefront to introduce next-generation technology and solutions to the Sri Lankan community, in line with its brand promise to deliver the future, today. In particular, Dialog continues to invest in Sri Lanka’s leading digital health and wellness platforms, such as Doc990, MyDoctor.lk and Yeheli.lk. Avidhrt is the latest addition to its suite of digital health services and we are pleased to make this affordable solution available at selected Dialog Customer Care Centres.”  

My Health Solutions Ltd Director/Chief Executive Officer Sameera Wijerathna said: “We are glad to partner with Dialog and Avidhrt as the exclusive medical service provider. We provide healthcare services to Sri Lankan consumers via digital mediums while ensuring and maintaining human interactions.  Through this revolutionary device, we ensure that anyone using an Avidhrt monitor can not only monitor their heart conditions via ECG but also get expert advice at the click of a button from a qualified doctor.” 

The Avidhrt Sense Device, system and method are patented technology in the United States of America.


Share This Article

Facebook Twitter


1. All comments will be moderated by the Daily FT Web Editor.

2. Comments that are abusive, obscene, incendiary, defamatory or irrelevant will not be published.

3. We may remove hyperlinks within comments.

4. Kindly use a genuine email ID and provide your name.

5. Spamming the comments section under different user names may result in being blacklisted.


Today's Columnists

Emerging signals of a US recession

Wednesday, 21 August 2019

US stocks plunge on fears of an economic downturn Last week’s turbulence in financial markets was a reaction to the fresh evidence of a possible recession in the US economy. The Dow Jones Industrials Average dropped a whopping 800 points or 3% last

The 1915 pogrom: Where were all the women?

Wednesday, 21 August 2019

The 1915 anti-Muslim pogrom in Sri Lanka (then Ceylon) is usually analysed through the lenses of ethnicity, religion, or class. Gender – and specifically women – appears to be absent in the narratives on this colonial-era conflict. Such absence i

The meaning of our slogans

Wednesday, 21 August 2019

Sri Lankans undoubtedly are inclined towards slogans, and the time of elections is the high season. They appear everywhere; on walls, bus stands, huge boulders, vehicles and even on the garments worn by the campaigners. Usually we are given somewhat

“Doing something” about social media?

Wednesday, 21 August 2019

Since the tragic terrorist incidents and pogroms of April and May, concerns about social media have been reverberating throughout our society. We are under pressure to “do something,” even without fully understanding the problems we seek to solve

Columnists More

Special Report